BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 8, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

1,000 Genomes Project Has Passed 1,000 Sequences Mark

Nov. 1, 2012
By Anette Breindl
The 1,000 Genomes Project has surpassed the 1,000 genomes mark. This week, the international consortium that is behind the sequencing effort reported on genome data from 1,092 individuals from 14 separate populations.
Read More

Vector-Triggered Innate Immune Activity Is Necessary for iPSCs

Oct. 31, 2012
By Anette Breindl
Researchers reported last week that the retroviral vector that is used for gene delivery in the generation of induced pluripotent stem cells, or iPSCs, does more than just ferry its cargo into cells. It activates the innate immune system – and that activation is critical for efficient reprogramming.
Read More

Antibody Goes from Delivery Guy to Targeted Therapy Star

Oct. 29, 2012
By Anette Breindl
Researchers at the Yale University School of Medicine have shown that an antibody that was originally isolated from a mouse model of lupus may be useful as a targeted cancer therapy.
Read More

Is IP Rewarding Wrong Part of Drug Discovery Process?

Oct. 29, 2012
By Anette Breindl
Intellectual property (IP) is a cornerstone of the drug discovery industry. But as that industry is changing, some are questioning whether that cornerstone is starting to do more harm than good, at least the way it currently is constructed.
Read More

Procedure Scrambles Eggs, Replaces Mitochondrial DNA

Oct. 25, 2012
By Anette Breindl
Through a procedure known as spindle transfer, or spindle complex-chromosomal transfer, scientists have created human eggs composed of the nuclear DNA from one person and the mitochondrial DNA from another.
Read More

Selectin Blocker Can Protect Blood Stem Cells from Chemo

Oct. 24, 2012
By Anette Breindl
Researchers from the Australian Mater Medical Research Institute, the University of Brisbane and U.S. biotech company GlycoMimetics Inc. have reported new insights into how blood stem cells are activated by selectins, and how blocking that activation may be able to protect them from the effects of chemotherapy and radiation.
Read More

'Agnostics' Venture Beyond Amyloid, Tau in Alzheimer's

Oct. 22, 2012
By Anette Breindl
NEW ORLEANS – Drug discovery for Alzheimer's disease finds itself in an odd place these days.
Read More

A Systematic Approach to Synergy Brings HIV Insight

Oct. 22, 2012
By Anette Breindl
By screening a thousand FDA-approved drugs in a multistep process, scientists have identified a set of drug combinations that work synergistically to inhibit HIV replication.
Read More

Opening the Black Box that Leads to Black Box Warning

Oct. 17, 2012
By Anette Breindl
NEW ORLEANS – Lemming myths aside, suicide is one behavior that cannot be modeled in animal studies. But some of the risk factors that increase suicide risk in humans can.
Read More

Early Intervention Brings New Chances; New Questions, too

Oct. 16, 2012
By Anette Breindl
NEW ORLEANS – During her professional life, Barbara Sahakian told the audience on Monday at the 2012 annual meeting of the Society for Neuroscience, the approach to mental health problems has undergone a "shift from attempts to treat chronic relapsing mental health problems after they occur to an attempt to prevent them . . . or at least detect early and treat effectively."
Read More
Previous 1 2 … 235 236 237 238 239 240 241 242 243 … 403 404 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Illustration of brain and brain waves, concept of focal seizure

    Hyperexcitability may be joint problem in epilepsy, dementia

    BioWorld
    The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing